NeuroSense Therapeutics
improves neuronal survival in als human cell model | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2024
Slide
11 of 27
Related slides by other companies
Larimar Therapeutics
Investor Presentation
November 2023
extends survival in deficient mice | Larimar Therapeutics
Akouos
IPO
June 2020
proof of concept data mediated delivery of recovered hearing in a knock out mouse model encoding human clarin can an | Akouos
Other recent decks by NeuroSense Therapeutics
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights